Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Total Liabilities (2010 - 2026)

Updated

Ani Pharmaceuticals (ANIP) posted Total Liabilities of $896.9 million for Q2 2026, down 1.0% from $906.24 million a year earlier but up 4.3% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Total Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Ani Pharmaceuticals' Total Liabilities came in at $899.65 million, up 2.1% from FY2024.

  • Annual Total Liabilities has increased for seven consecutive years, with a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
  • In prior years, Ani Pharmaceuticals' Total Liabilities was $880.79 million in FY2024 (+86.7%), $471.67 million in FY2023 (+5.7%), $446.4 million in FY2022 (+2.0%) and $437.71 million in FY2021 (+64.9%).
  • Quarterly Total Liabilities has run from a low of $279.05 million in Q3 2021 to a high of $906.24 million in Q2 2025 over five years.
  • On a year-over-year basis, Total Liabilities increased in six of the last eight quarters, with growth averaging 45.5%.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was Q2 2025, with growth of 94.9%; the weakest was Q1 2026, with a decline of 1.6%.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $859.67 million (Q1 2026), $899.65 million (Q4 2025) and $902.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn 896.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 896.90 Mn
Mar 31, 2026 859.67 Mn
Dec 31, 2025 899.65 Mn
Sep 30, 2025 902.34 Mn
Jun 30, 2025 906.24 Mn
Mar 31, 2025 873.81 Mn
Dec 31, 2024 880.79 Mn
Sep 30, 2024 881.43 Mn
Jun 30, 2024 464.99 Mn
Mar 31, 2024 462.56 Mn
Dec 31, 2023 471.67 Mn
Sep 30, 2023 460.05 Mn
Jun 30, 2023 449.72 Mn
Mar 31, 2023 450.59 Mn
Dec 31, 2022 446.40 Mn
Sep 30, 2022 427.29 Mn
Jun 30, 2022 439.23 Mn
Mar 31, 2022 423.60 Mn
Dec 31, 2021 437.71 Mn
Sep 30, 2021 279.05 Mn
API Access

Ani Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ANIP&period=max&api_key=YOUR_API_KEY